Ultrastructural alterations induced by 1-methyl-4-phenylpyridinium (MPP+) in canine substantia nigra and rat mesencephalon in vitro
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
1983 • 4,822 citations
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
1983 • 2,149 citations
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
1979 • 1,356 citations
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
1985 • 1,253 citations
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
1985 • 1,236 citations
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
1984 • 1,092 citations
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
1984 • 1,007 citations
Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
1984 • 1,005 citations
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
1984 • 772 citations
1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra
1984 • 423 citations
Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys
1984 • 323 citations
Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
1985 • 290 citations
Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin
1986 • 289 citations
Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes
1985 • 270 citations
Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism
1986 • 250 citations
IV. MPTP, MPP+ and mitochondrial function
1987 • 249 citations
Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
1984 • 221 citations
IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects
1985 • 210 citations
Evidence for neuromelanin involvement in MPTP-induced neurotoxicity
1987 • 120 citations
1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Destroys Dopamine Neurons in Explants of Rat Embryo Mesencephalon
1984 • 113 citations
Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum
1985 • 110 citations
Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to rats
1985 • 88 citations
1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture
1985 • 83 citations
The development of the dog nigrostriatal system in organotypic culture
1981 • 30 citations